1. Home
  2. CALM vs DYN Comparison

CALM vs DYN Comparison

Compare CALM & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cal-Maine Foods Inc.

CALM

Cal-Maine Foods Inc.

N/A

Current Price

$69.55

Market Cap

3.1B

ML Signal

N/A

DYN

Dyne Therapeutics Inc.

N/A

Current Price

$16.10

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CALM
DYN
Founded
1957
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
CALM
DYN
Price
$69.55
$16.10
Analyst Decision
Hold
Strong Buy
Analyst Count
4
17
Target Price
★ $68.33
$34.33
AVG Volume (30 Days)
833.8K
★ 2.1M
Earning Date
01-06-2027
11-05-2026
Dividend Yield
★ 1.53%
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $2,911,632,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.37
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$60.13
$14.00
52 Week High
$95.25
$27.31

Technical Indicators

Market Signals
Indicator
CALM
DYN
Relative Strength Index (RSI) 58.21 41.96
Support Level $60.91 $14.43
Resistance Level $80.00 $19.48
Average True Range (ATR) 2.82 0.93
MACD 0.65 -0.17
Stochastic Oscillator 80.38 8.54

Price Performance

Historical Comparison
CALM
DYN

About CALM Cal-Maine Foods Inc.

Cal-Maine Foods Inc is an egg company in the U.S. Its shell egg portfolio includes conventional, specialty, cage-free, nutritionally enhanced, organic, brown, pasture-raised, and free-range eggs. The Company operates through the Conventional Shell Eggs, Specialty Shell Eggs and Prepared Foods segments, with Conventional Shell Eggs generating maximum revenue. The Conventional Shell Eggs segment consists mainly of the production, grading, packaging, marketing and distribution of conventional shell eggs, including Sunups and Sunny Meadow. The Company sells its products to grocery store chains, club stores, independent supermarkets, and foodservice distributors serving restaurants, convenience stores, healthcare and education facilities, and hotels throughout the U.S.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: